Expression of Natural Killer Cell Regulatory MicroRNA by Uveal Melanoma Cancer Stem Cells

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 2016 Aug 28

PMID 27565163

Citations 15

Authors

Powrnima Joshi

Mitra Kooshki

Wayne Aldrich

Daniel Varghai

Maciej Zborowski

Arun D Singh

Pierre L Triozzi

Affiliations

Soon will be listed here.

Abstract

Natural killer (NK) cells are implicated in the control of metastasis in uveal melanoma, a process that has been ascribed to its cancer stem cell subpopulation. NK cell activation is regulated by specific microRNA (miR). The NK cell sensitivity and regulatory miR production of uveal melanoma cancer stem cells was examined. Cancer stem cells enriched from aggressively metastatic MUM2B uveal melanoma cells by selecting CD271 cells or propagating as non-adherent spheres in stem-cell supportive were more resistant to NK cell cytolysis than cancer stem cells enriched from less aggressively metastatic OCM1 uveal melanoma cells. Both MUM2B and OCM1 cells expressed and secreted NK cell regulatory miRs, including miR 146a, 181a, 20a, and 223. MUM2B cells expressed and secreted miR-155; OCM1 cells did not. Transfecting MUM2B cells with anti-miR-155 increased NK cell sensitivity. CD271 cells were identified in the blood of patients with metastatic uveal melanoma and were characterized by low expression of melanocyte differentiation determinants and by the ability to form non-adherent spheres in stem-cell supportive media. These cells also expressed NK cell regulatory miRs, including miR-155. These results indicate that uveal melanoma cancer stem cells can vary in their sensitivity to NK cell lysis and their expression of NK cell regulatory miRs. Circulating CD271 cells from patients with metastatic uveal melanoma manifest cancer stem cell features and express miRs associated with NK cell suppression, including miR-155, that may contribute to metastatic progression.

Citing Articles

MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma.

Fawzy M, Ibrahiem A, Bayomy N, Makhdoom A, Alanazi K, Alanazi A Diagnostics (Basel). 2023; 13(6).

PMID: 36980512 PMC: 10047208. DOI: 10.3390/diagnostics13061205.

Genetics and RNA Regulation of Uveal Melanoma.

Barbagallo C, Stella M, Broggi G, Russo A, Caltabiano R, Ragusa M Cancers (Basel). 2023; 15(3).

PMID: 36765733 PMC: 9913768. DOI: 10.3390/cancers15030775.

MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression.

Wroblewska J, Lach M, Rucinski M, Piotrowski I, Galus L, Suchorska W Front Cell Dev Biol. 2023; 10:1008901.

PMID: 36619870 PMC: 9814164. DOI: 10.3389/fcell.2022.1008901.

The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy.

Dong L, Tian X, Zhao Y, Tu H, Wong A, Yang Y Int J Mol Sci. 2022; 23(23).

PMID: 36499102 PMC: 9736803. DOI: 10.3390/ijms232314775.

Development of a 3-MicroRNA Signature and Nomogram for Predicting the Survival of Patients with Uveal Melanoma Based on TCGA and GEO Databases.

Zuo J, Ye H, Tang J, Lu J, Wan Q J Ophthalmol. 2022; 2022:9724160.

PMID: 36457950 PMC: 9708375. DOI: 10.1155/2022/9724160.

References

Onken M, Worley L, Tuscan M, Harbour J . An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn. 2010; 12(4):461-8. PMC: 2893630. DOI: 10.2353/jmoldx.2010.090220. View

Tseng H, Inagaki A, Bui V, Cacalano N, Kasahara N, Man Y . Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells. J Cancer. 2015; 6(9):866-76. PMC: 4532984. DOI: 10.7150/jca.11527. View

Pietra G, Manzini C, Vitale M, Balsamo M, Ognio E, Boitano M . Natural killer cells kill human melanoma cells with characteristics of cancer stem cells. Int Immunol. 2009; 21(7):793-801. DOI: 10.1093/intimm/dxp047. View

Repp A, Mayhew E, Apte S, Niederkorn J . Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol. 2000; 165(2):710-5. DOI: 10.4049/jimmunol.165.2.710. View

Ji J, Zheng X, Forgues M, Yamashita T, Wauthier E, Reid L . Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma. Hepatology. 2015; 62(3):829-40. PMC: 4549211. DOI: 10.1002/hep.27886. View

Folberg R, Kadkol S, Frenkel S, Valyi-Nagy K, Jager M, Peer J . Authenticating cell lines in ophthalmic research laboratories. Invest Ophthalmol Vis Sci. 2008; 49(11):4697-701. PMC: 2576485. DOI: 10.1167/iovs.08-2324. View

Sun X, Zhang J, Hou Z, Han Q, Zhang C, Tian Z . miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression. Cell Cycle. 2015; 14(2):243-52. PMC: 4352959. DOI: 10.4161/15384101.2014.977112. View

Fehniger T, Wylie T, Germino E, Leong J, Magrini V, Koul S . Next-generation sequencing identifies the natural killer cell microRNA transcriptome. Genome Res. 2010; 20(11):1590-604. PMC: 2963822. DOI: 10.1101/gr.107995.110. View

Vetter C, Lieb W, Brocker E, Becker J . Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma. Br J Cancer. 2004; 91(8):1495-9. PMC: 2409941. DOI: 10.1038/sj.bjc.6602123. View

10.

Vroling L, Lind J, de Haas R, Verheul H, van Hinsbergh V, Broxterman H . CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients. Br J Cancer. 2009; 102(2):268-75. PMC: 2816651. DOI: 10.1038/sj.bjc.6605477. View

11.

Blom D, de Waard-Siebinga I, Apte R, Luyten G, Niederkorn J, Jager M . Effect of hyperthermia on expression of histocompatibility antigens and heat-shock protein molecules on three human ocular melanoma cell lines. Melanoma Res. 1997; 7(2):103-9. DOI: 10.1097/00008390-199704000-00003. View

12.

Cubillos-Ruiz J, Baird J, Tesone A, Rutkowski M, Scarlett U, Camposeco-Jacobs A . Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer. Cancer Res. 2012; 72(7):1683-93. PMC: 3319850. DOI: 10.1158/0008-5472.CAN-11-3160. View

13.

Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, Stanietsky N . Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol. 2008; 9(9):1065-73. DOI: 10.1038/ni.1642. View

14.

Thill M, Berna M, Grierson R, Reinhart I, Voelkel T, Piechaczek C . Expression of CD133 and other putative stem cell markers in uveal melanoma. Melanoma Res. 2011; 21(5):405-16. DOI: 10.1097/CMR.0b013e328348db10. View

15.

Cichocki F, Felices M, McCullar V, Presnell S, Al-Attar A, Lutz C . Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling. J Immunol. 2011; 187(12):6171-5. PMC: 3237765. DOI: 10.4049/jimmunol.1100835. View

16.

Hallermalm K, Seki K, De Geer A, Motyka B, Bleackley R, Jager M . Modulation of the tumor cell phenotype by IFN-gamma results in resistance of uveal melanoma cells to granule-mediated lysis by cytotoxic lymphocytes. J Immunol. 2008; 180(6):3766-74. DOI: 10.4049/jimmunol.180.6.3766. View

17.

Damato B, Coupland S . Translating uveal melanoma cytogenetics into clinical care. Arch Ophthalmol. 2009; 127(4):423-9. DOI: 10.1001/archophthalmol.2009.40. View

18.

Elemam N, Mekky R, El-Ekiaby N, El Sobky S, El Din M, Esmat G . Repressing PU.1 by miR-29a∗ in NK cells of HCV patients, diminishes its cytolytic effect on HCV infected cell models. Hum Immunol. 2015; 76(9):687-94. DOI: 10.1016/j.humimm.2015.09.021. View

19.

Blom D, Luyten G, Mooy C, Kerkvliet S, Zwinderman A, Jager M . Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma. Invest Ophthalmol Vis Sci. 1997; 38(9):1865-72. View

20.

Zhang G, Xiao H, Tian H, Liu Z, Xia S, Zhou T . Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression. Int J Mol Med. 2013; 31(6):1375-80. DOI: 10.3892/ijmm.2013.1348. View